ATE166572T1 - Ranitidin enthaltende kautabletten - Google Patents

Ranitidin enthaltende kautabletten

Info

Publication number
ATE166572T1
ATE166572T1 AT93922535T AT93922535T ATE166572T1 AT E166572 T1 ATE166572 T1 AT E166572T1 AT 93922535 T AT93922535 T AT 93922535T AT 93922535 T AT93922535 T AT 93922535T AT E166572 T1 ATE166572 T1 AT E166572T1
Authority
AT
Austria
Prior art keywords
tablets containing
chewable tablets
containing ranitidine
ranitidine
advantage
Prior art date
Application number
AT93922535T
Other languages
English (en)
Inventor
Alan Bye
Jill Evans
Paul Derrick Huckle
Laurence Francis Lacey
Peter John Rue
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE166572T1 publication Critical patent/ATE166572T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93922535T 1992-10-13 1993-10-11 Ranitidin enthaltende kautabletten ATE166572T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221414A GB9221414D0 (en) 1992-10-13 1992-10-13 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE166572T1 true ATE166572T1 (de) 1998-06-15

Family

ID=10723323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93922535T ATE166572T1 (de) 1992-10-13 1993-10-11 Ranitidin enthaltende kautabletten

Country Status (25)

Country Link
US (1) US5593685A (de)
EP (2) EP0788789A1 (de)
JP (1) JP2918691B2 (de)
KR (1) KR950703327A (de)
AT (1) ATE166572T1 (de)
AU (1) AU676690B2 (de)
BG (1) BG99567A (de)
CA (1) CA2147000A1 (de)
CZ (1) CZ94495A3 (de)
DE (1) DE69318844T2 (de)
ES (1) ES2117718T3 (de)
GB (1) GB9221414D0 (de)
HU (2) HUT72497A (de)
IL (1) IL107255A (de)
MX (1) MX9306333A (de)
NO (1) NO951432L (de)
NZ (1) NZ256681A (de)
OA (1) OA10144A (de)
PH (1) PH31433A (de)
PL (1) PL174359B1 (de)
SG (1) SG49850A1 (de)
SK (1) SK48395A3 (de)
TW (1) TW271405B (de)
WO (1) WO1994008560A1 (de)
ZA (1) ZA937544B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
AU7468096A (en) * 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
DE19639343C2 (de) * 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
GB9715423D0 (en) * 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
US6086920A (en) * 1998-08-12 2000-07-11 Fuisz Technologies Ltd. Disintegratable microspheres
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6491540B1 (en) * 1999-09-20 2002-12-10 Jack Barreca Center-filled supplement gum
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
FR2636532B1 (fr) * 1988-09-20 1993-11-19 Glaxo Group Ltd Compositions pharmaceutiques
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
ES2077417T3 (es) * 1991-04-04 1995-11-16 Procter & Gamble Composiciones farmaceuticas ingeribles para tratar malestares del tracto gastrointestinal superior.
WO1992017161A1 (en) * 1991-04-04 1992-10-15 The Procter & Gamble Company Chewable antacid compositions
DE69233130T2 (de) * 1991-05-28 2005-06-02 Mcneil-Ppc, Inc. Kaubare zusammensetzung zur arzneimittelfreisetzung
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
IL107255A0 (en) 1994-01-25
AU5143493A (en) 1994-05-09
WO1994008560A1 (en) 1994-04-28
NZ256681A (en) 1997-10-24
EP0664697A1 (de) 1995-08-02
SK48395A3 (en) 1995-11-08
DE69318844T2 (de) 1998-10-15
CA2147000A1 (en) 1994-04-28
AU676690B2 (en) 1997-03-20
TW271405B (de) 1996-03-01
KR950703327A (ko) 1995-09-20
NO951432L (no) 1995-05-12
EP0664697B1 (de) 1998-05-27
BG99567A (en) 1995-12-29
US5593685A (en) 1997-01-14
PL174359B1 (pl) 1998-07-31
MX9306333A (es) 1995-01-31
EP0788789A1 (de) 1997-08-13
DE69318844D1 (de) 1998-07-02
HU211847A9 (en) 1995-12-28
PH31433A (en) 1998-11-03
HUT72497A (en) 1996-05-28
CZ94495A3 (en) 1995-10-18
JP2918691B2 (ja) 1999-07-12
SG49850A1 (en) 1998-06-15
ZA937544B (en) 1994-04-21
PL308356A1 (en) 1995-07-24
GB9221414D0 (en) 1992-11-25
HU9501053D0 (en) 1995-06-28
ES2117718T3 (es) 1998-08-16
JPH08502272A (ja) 1996-03-12
IL107255A (en) 1998-07-15
OA10144A (en) 1996-12-18
NO951432D0 (no) 1995-04-12

Similar Documents

Publication Publication Date Title
ATE166572T1 (de) Ranitidin enthaltende kautabletten
FI882263A7 (fi) Vanadiinitetrakloridin stabilointi.
NO884028D0 (no) Stabilisering av leireholdige formasjoner.
IT8819213A0 (it) Procedimento e dispositivo per la realizzazione di mescole di caucciu'.
MX9202513A (es) Empacadura de columna estructurada con inversion mejorada.
DK465488A (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
ATE78166T1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
NO934197D0 (no) Vitamin D-3-analoger
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
FI873429A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
DE68914711D1 (de) 1,4-Disubstituierte-2,3,4,6-tetrahydroxy-1,4-diphosphorinan und ihre Oxide oder Sulfides.
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ATE54822T1 (de) Kosmetikum.
KR880701547A (ko) 이부프로펜 또는 플루르비프로펜을 사용한 치은염 치료
IT8421358A0 (it) Derivato della ranitidina utile nel trattamento dell'ulcera.
ATE45957T1 (de) 13alpha-alkyl-17beta-(3-acyloxy-propyl)-gonane.
KR940020702U (ko) 산소의 용존량을 증가시키기 위한 폭기장치
KR880009390U (ko) 때밀이구
KR880006933U (ko) 노이즈 방지용 3단자 콘덴서
IT8019643A0 (it) Dell'ozono dall'atmosfera. procedimento di eliminazione
IT8603003V0 (it) Crick martinetto del 2000
KR870016530U (ko) 승강기 장난방지장치

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties